Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Gemfibrozil, and what generic alternatives are available?

Gemfibrozil is a drug marketed by Impax Pharms, Caribe Holdings, Sandoz, Aurobindo Pharma Ltd, Purepac Pharm, Apotex, Invagen Pharms, Sun Pharm Inds Inc, Watson Labs, Mylan, Teva, Cadila Pharms Ltd, Chartwell Molecules, Northstar Hlthcare, and Hikma Pharms. and is included in eighteen NDAs.

The generic ingredient in GEMFIBROZIL is gemfibrozil. There are twenty drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the gemfibrozil profile page.

Summary for Tradename: GEMFIBROZIL

Suppliers / Packagers: see list51
Bulk Api Vendors: see list69
Clinical Trials: see list7
Patent Applications: see list5,580
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GEMFIBROZIL at DailyMed

Pharmacology for Tradename: GEMFIBROZIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Pharms
TABLET;ORAL078207-001Jun 1, 2007ABRXNoNo► Subscribe► Subscribe
Hikma Pharms
TABLET;ORAL078599-001Aug 16, 2010ABRXNoNo► Subscribe► Subscribe
Invagen Pharms
TABLET;ORAL077836-001Jul 27, 2006ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
TABLET;ORAL202726-001Sep 16, 2015ABRXNoNo► Subscribe► Subscribe
Watson Labs
TABLET;ORAL074156-001Oct 24, 1994DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus